Stock analysts at Cowen and Company decreased their price objective on shares of Healthcare Realty Trust (NYSE:HR) from $22.00 to $19.00 in a report issued on Thursday, Stock Ratings Network reports. The firm currently has an “underperform” rating on the stock. Cowen and Company’s target price would suggest a potential downside of 16.56% from the stock’s previous close.
Healthcare Realty Trust (NYSE:HR) traded down 0.13% on Thursday, hitting $22.77. 321,021 shares of the company’s stock traded hands. Healthcare Realty Trust has a 1-year low of $21.78 and a 1-year high of $30.59. The stock’s 50-day moving average is $23.87 and its 200-day moving average is $26.59. The company’s market cap is $2.183 billion.
Healthcare Realty Trust (NYSE:HR) last released its earnings data on Tuesday, July 30th. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.28 by $0.04. The company had revenue of $84.05 million for the quarter, compared to the consensus estimate of $82.27 million. During the same quarter in the prior year, the company posted $0.34 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. On average, analysts predict that Healthcare Realty Trust will post $1.10 earnings per share for the current fiscal year.
Healthcare Realty Trust Incorporated (NYSE:HR) is a self-managed and self-administered real estate investment trust (REIT) that owns, acquires, manages, finances and develops income-producing real estate properties associated with the delivery of outpatient healthcare services throughout the United States.